Clinical Trials on Endodontically Treated Teeth in Germany

Total 2447 results

Johannes Gutenberg University Mainz
Pfizer

Unknown

Varenicline for Alcohol Dependence

Alcohol Dependence

Germany
Eli Lilly and Company

Completed

A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Boehringer Ingelheim

Completed

A Study Based on Data From German Registries That Looks at Characteristics of People Who Take the Medicine Empagliflozin for Type 2 Diabetes (EDCOS)

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)

Diabetes Mellitus, Type 2

Germany
InQpharm Group

Completed

Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects

Hyperglycemia | Prediabetes

Germany
Eli Lilly and Company

Completed

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

Diabetes Mellitus, Type 2

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets

Diabetes Mellitus, Type 2

Germany
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany
Beta-Stim Ltd.
Meditrial Europe Ltd.

Completed

Balance System Study in Type 2 Diabetic Patients

Obesity | Type 2 Diabetes

Germany
ikfe-CRO GmbH
Novo Nordisk A/S; IKFE Institute for Clinical Research and Development

Completed

Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany
University Medical Center Goettingen

Recruiting

Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes (PDA-MAPS)

Pancreatic Cancer

Germany
Eli Lilly and Company

Completed

A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People

Diabetes Mellitus, Type 2

Germany
Krankenhaus Nordwest

Completed

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Resectable Prancreas Carcinoma

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

Diabetes Mellitus, Type 2

Germany
University of Hohenheim
University Hospital Tuebingen; Karl-Olga-Krankenhaus Stuttgart

Unknown

Early Changes of Diabetes Parameters After Obesity Therapy (ECODO)

Bariatric Surgery Candidate

Germany
Eli Lilly and Company

Completed

A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Ludwig-Maximilians - University of Munich

Completed

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM) (DFG_5)

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Germany
ikfe-CRO GmbH
Sanofi; IKFE Institute for Clinical Research and Development

Completed

Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novartis

Completed

Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy (BEST)

Breast Cancer | Cancer-related Fatigue

Germany
Novo Nordisk A/S

Completed

Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes (ProMix)

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Terminated

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Sanofi

Completed

A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes (ELDERLY-T)

Type 2 Diabetes Mellitus (T2DM)

Germany
Michael A. Nauck

Completed

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Type 2 Diabetes

Germany
University of Erlangen-Nürnberg Medical School

Recruiting

Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes (SEMA)

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Completed

A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Ingredia S.A.
BioTeSys GmbH

Completed

Investigation of Milk Peptides (Pep2Dia®) on Postprandial Blood Glucose Profile in Prediabetic Subjects

Prediabetic State

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
St. Franziskus Hospital
Deutsches Institut für Gefäßmedizinische Gesundheitsforschung gGmbH (DIGG); Deutsche Gesellschaft für Gefäßchirurgie und Gefäßmedizin

Completed

Registry of First-line Treatments in Patients With Critical Limb Ischemia (CRITISCH)

Critical Limb Ischemia

Germany
University Hospital Tuebingen
Merck Sharp & Dohme LLC

Withdrawn

Characterization of Beta Cell Failure

Diabetes | Metabolic Syndrome

Germany
Johannes Gutenberg University Mainz
Boehringer Ingelheim

Completed

Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics (EmDia)

Diabetes Mellitus, Type 2 | Diastolic Dysfunction

Germany
Novo Nordisk A/S

Completed

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany

3

Subscribe